Poor Responders to Intravenous Omeprazole in Patients with Peptic Ulcer Bleeding

Hepato-Gastroenterology

Volumn 51, Issue 55, 2004, Pages 316-319

  Hsieh, Yu Hsi ^b   Lin, Hwai Jeng ^a,f   Tseng, Guan Ying ^c   Perng, Chin Lin ^a   Wang, Kun ^d   Lo, Wen Ching ^e   Chang, Full Young ^a   Lee, Shou Dong ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c Ton Yen General Hospital   (Taiwan)

^d CARDINAL TIEN HOSPITAL   (Taiwan)

^e Taipei Municipal Chung Hsiao Hospital   (Taiwan)

^f VGH TAIPEI   (Taiwan)

Author keywords

Omeprazole; Peptic ulcer; pH; Poor response; Rebleeding

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG DOSE REGIMEN; ENDOSCOPIC SURGERY; FEMALE; HEMOSTASIS; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER BLEEDING; PRIORITY JOURNAL; RECURRENT DISEASE; STOMACH PH; TREATMENT FAILURE;

AGED; ANTI-ULCER AGENTS; ENDOSCOPY, GASTROINTESTINAL; FEMALE; HEMOSTASIS, ENDOSCOPIC; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; OMEPRAZOLE; PEPTIC ULCER HEMORRHAGE; RECURRENCE;

EID: 10744226074     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Consensus Development Panel: Consensus statement on therapeutic endoscopy and bleeding ulcers. Gastrointest Endosc 1990; 36:S62-65.
2. Cook DJ, Guyatt GH, Salena BJ, Laine LA: Endoscopic therapy for acute nonvariceal upper gastrointestinal hemorrhage: a meta-analysis. Gastroenterology 1992; 102:139-148.
3. Lin HJ, Lo WC, Lee FY, Perng CL, Tseng GY: A prospective randomized comparative trial showing that omeprazole prevents rebleeding in patients with bleeding peptic ulcer after successful endoscopic therapy. Arch Intern Med. 1998; 158:54-58.
4. Lau JYW, Sung JJY, Lee KKC, Yung MY, Wong SKH, Wu JCY, Chan FKL, Ng EKW, You JHS, LCW, Chan ACW, Chung SCS: Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N Engl J Med 2000; 343:310-316.
5. Lin HJ, Perng CL, Lee FY, Tsai YT, Lee CH, Lee SD: Clinical courses and predictors for rebleeding in patients with peptic ulcer s and non-bleeding visible vessels: a prospective study. Gut 1994; 35:1389-1393.
6. Lin HJ, Perng CL, Wang K, Lee SD, Lee CH: Long-term results of heater probe thermocoagulation for patients with massive peptic ulcer bleeding: a prospective observation. Am J Gastroenterol 1995; 90:44-47.
7. Blatchford O, Murray WR, Blatchford M: A risk score to predict need for treatment for upper gastrointestinal haemorrhage. Lancet 2000; 356:1318-1321.
8. Lanas A, Artal A, Bias JM, Arroyo MT, Lopez-Zaborras J, Sainz R: Effect of parenteral omeprazole and ranitidine on gastric pH and the outcome of bleeding peptic ulcer. Clin Gastroenterol 1995; 21(2):103-106.
9. Green FW Jr, Kaplan MM, Curtis LE, Levine PH: Effect of acid and pepsin on blood coagulation and platelet aggregation: a possible contributor to prolonged gastroduodenal mucosal hemorrhage. Gastroenterology 1978; 74:38-43.
10. Bianchi PG, Parente F: Duodenal ulcers resistant to H2-blockers: An emerging therapeutic problem. Scand J Gastroenterol 1988; 23(Suppl 153):81-88.
11. Savarino V, Mela GS, Zentilin P, Celle G: Duodenal ulcer resistant to usual omeprazole dose. Am J Gastroenterol 1990; 85:618-619.
12. Clissold SP, Campoli-Richards DM: Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome. Drugs 1986; 32:15-47.
13. Aandersen J, Strom M, Neasdal J, Lere K, Wallan A: Intravenous omeprazole: effect of a loading dose on 24-h intragastric pH. Aliment Pharmacol Ther 1990; 4(1):65-72.
14. Savarino V, Mela GS: H2 antagonist and omeprazole nonresponders. Dig Dis Sci 1991; 36(8):1172-1173.
15. Leite LP, Johnston BT, Just RJ, Castell DO: Pesistent acid secretion during omeprazole therapy: a study of gastricacid profiles in patients demonstrating failure of omeprazole therapy. Am J Gastroenterol 1996; 91(8):1527-1531.
16. Klingenberg-Knol EC, Meuwissen SG: Combined gastric and oesophageal 24-hour pH monitoring and esophageal manometry n patients with reflux disease, resistant to treatment with omeprazole. Aliment Pharmacol Ther 1990; 4(5):485-495.
17. Savarino V, Mela GS, Zentilin P, Cutela P, Mele MR, Vigneri S, Celle G: Variability in individual response to various doses of omeprazole, implications of antiulcer therapy. Dig Dis Sci 1994; 39(1):161-168.
18. Walt RP, Reynolds JR, Langman MJS, Smart HL, Kitchingman G, Somerville KW, Hawkey CJ: Gut 1985; 26:902-906.
19. Brunner G, Luna P, Thiesemann C: Drugs for pH control in upper gastrointestinal bleeding. Aliment Phamacol Ther 1995; 9(Suppl 1):47-50.
20. Brunner GHG, Thiesemann C: The potential clinical role of intravenous omeprazole. Digestion 1992; 51(Suppl 1):17-20.
21. Hatlebakk JG, Berstad A, Carling L, et al: Lansoprazole versus omeprazole in short term treatment of reflux esophagitis. Results of a Scandinavian multicenter trial. Gastroenterology 1992; 102:A80.
22. Laursen LS, Bondesen S, Hansen J, et al: Omeprazole mg or 40 mg for the treatment of gastroesophageal reflux disease? A double blind comparative study. Gastroenterology 1992; 102:A110.
23. Just R, Gideon RM, Castell D: Omeprazole resistance in patients with gastroesophageal reflux disease (GERD). Gastroenterology 1994; 106:A101.
24. Kiilerich S, Rannem T, Elsborg L: Effect of intravenous infusion of omeprazole and ranitidine on twenty-four-hour intragastric pH in patients with a history of duodenal ulcer. Digestion 1995; 56:25-30.
25. Gupta PK, Flockhart N, Soukhova N, Fleischer DE, Benjamin SB: Omeprazole metabolism in patients with refractory gastroesophageal reflux (GER). Gastroenterology 1994; 106:A84.
26. Cederberg C, Andersson T, Skanberg I: Omeprazole: Pharmacokinetics and metabolism in man. Scand J gastroenterol 1989; 24(Suppl 166):33-40.
27. Lanbenz J, Tillenburg B, Peitz U, Idstrom JP, Verdu EF, Stolte M, Borsch G, Blum AL: Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer. Gastroenterology 1996; 110:725-732.
28. Labenz J, Peitz U, Leusing C, Tillenburg B, Blum AL, Borsch G: Efficacy of primed infusions with high dose ranitidine and omeprazole to maintain high intragastric pH in patients with peptic ulcer bleeding: a prospective ran' domised controlled study. Gut 1997; 40:36-41.
29. Lam SK: Pathogenesis and pathophysiology of duodenal ulcer. Clin Gastroenterol 1984; 13:447.